These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TCR validation toward gene therapy for cancer. Green EW; Bunse L; Bozza M; Sanghvi K; Platten M Methods Enzymol; 2019; 629():419-441. PubMed ID: 31727252 [TBL] [Abstract][Full Text] [Related]
9. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy. Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318 [TBL] [Abstract][Full Text] [Related]
10. Preclinical development of T cell receptor gene therapy. Bendle GM; Haanen JB; Schumacher TN Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326 [TBL] [Abstract][Full Text] [Related]
11. T-cell receptor gene therapy of established tumors in a murine melanoma model. Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006 [TBL] [Abstract][Full Text] [Related]
12. Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function. Thomas S; Mohammed F; Reijmers RM; Woolston A; Stauss T; Kennedy A; Stirling D; Holler A; Green L; Jones D; Matthews KK; Price DA; Chain BM; Heemskerk MHM; Morris EC; Willcox BE; Stauss HJ Nat Commun; 2019 Oct; 10(1):4451. PubMed ID: 31575864 [TBL] [Abstract][Full Text] [Related]
13. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
14. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR. Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763 [TBL] [Abstract][Full Text] [Related]
15. Targeting self-antigens through allogeneic TCR gene transfer. de Witte MA; Coccoris M; Wolkers MC; van den Boom MD; Mesman EM; Song JY; van der Valk M; Haanen JB; Schumacher TN Blood; 2006 Aug; 108(3):870-7. PubMed ID: 16861342 [TBL] [Abstract][Full Text] [Related]
16. Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies. van Loenen MM; de Boer R; Hagedoorn RS; van Egmond EH; Falkenburg JH; Heemskerk MH Haematologica; 2011 Mar; 96(3):477-81. PubMed ID: 21109688 [TBL] [Abstract][Full Text] [Related]